A regulator gene mutation (capR) that causes increased synthesis of capsular polysaccharide and derepressed synthesis of several enzymes involved in polysaccharide synthesis also derepresses phosphomannose isomerase (PMI) synthesis. In contrast, a second mutation (capS, which maps separately from capR) that causes increased production of the same polysaccharide does not lead to increased synthesis of PMI (nor of several of the other enzymes involved in polysaccharide synthesis (5, 7) ]. The wild-type strain (capR+, capS+) produces clones that are nonmucoid, whereas mutations at either capR or capS give rise to mucoid clones ( Fig. 1;  references 5, 7) . The mucoidness is due to the production of large quantities of capsular polysaccharide. CapR is cotransduced with ProC 20% of the time (5, 7), whereas capS maps, by time of entry experiments (Fig. 2) , within 3.5 min of the gene controlling tryptophan synthesis (trp). Several enzymes probably involved in synthesis of capsular polysaccharide are elevated in extracts of capR-type mucoid mutants (5). In contrast, none of these enzymes [with the possible exception of GDP-L-fucose synthetase (Lieberman and Markovitz, unpublished data)] is elevated in extracts of capS mucoid mutants, as described in this paper. The present study is concerned with the effect of capR6, capR9, and capS mutations on PMI synthesis in man+ and in man-i and man-2 (PMI-deficient) strains. Data on the production of polysaccharide in strains with combinations of the above mutations are also presented and discussed.
Previous results showed that phosphomannose isomerase (PMI)-deficient mutants were also deficient in synthesis of capsular polysaccharide (8) that contains L-fucose (5) . A postulated scheme of biosynthesis of the polysaccharide included PMI as an enzyme necessary for synthesis of the polysaccharide precursor of L-fucOse [guanosine diphosphate (GDP)-L-fucose] from glucose (8) . Capsular polysaccharide synthesis is controlled by two regulator genes, capR and capS [previously designated R1 and R2 (5, 7) ]. The wild-type strain (capR+, capS+) produces clones that are nonmucoid, whereas mutations at either capR or capS give rise to mucoid clones ( Fig. 1 ; references 5, 7). The mucoidness is due to the production of large quantities of capsular polysaccharide. CapR is cotransduced with ProC 20% of the time (5, 7), whereas capS maps, by time of entry experiments (Fig. 2) , within 3.5 min of the gene controlling tryptophan synthesis (trp). Several enzymes probably involved in synthesis of capsular polysaccharide are elevated in extracts of capR-type mucoid mutants (5) . In contrast, none of these enzymes [with the possible exception of GDP-L-fucose synthetase (Lieberman and Markovitz, unpublished data)] is elevated in extracts of capS mucoid mutants, as described in this paper. The present study is concerned with the effect of capR6, capR9, and capS mutations on PMI synthesis in man+ and in man-i and man-2 (PMI-deficient) strains. Data on the production of polysaccharide in strains with combinations of the above mutations are also presented and discussed.
MATERIALS AND METHODS
Bacteria and bacteriophage. Donor strain AB 311 (from E. Adelberg) is a bacteriophage T6-sensitive, threonine-requiring strain with the following order of entry of markers: origin-histidine (his)-tryptophan (trp)-galactose (gal) (9, 10). Donor strains AB 259 and AB 261 (from E. Adelberg) were described previously (9, 10) . The origin of the proline-negative (proC) strain MC117 was described previously, and strains MC118 and MC119 are mannose-negative derivatives of strain MC117 continaing man-i and man-2, respectively (8) . Cap R9 and cap R6 alleles were transduced into strains MC117, MC118, and MClI9 by use of bacteriophage P1 grown on strains that were capR9 proC+ or capR6 proC+ and selecting for proC+ transductants. The characteristics of these strains are indicated in Results. The isolation of strain MC 120 was described (7) . It is mucoid owing to a mutation (designated cap SI) at a locus near trp, as demonstrated in Results. Strain MC 120 requires leucine (leu), proline (pro), purine (pur), and tryptophan for growth, and is bacteriophage T6-resistant, bacteri-FIG. 1. Strain MC117 (cap R+ man+; left) and strain MC121 (cap R9 man+; right) after growth at 37 C on glucose-containing M-9 minimal agar. ophage P1-immune, and F-. Its genotype is leu-1, proC, purE, trp-1.
Media. M-9 minimal medium (1) was supplemented as described previously (8) ; 0.6% glucose was replaced by 0.6% mannose where mannose is indicated.
Conditions and citations for mating experiments, enzymatic analyses, transductions, and protein determinations are recorded in earlier reports (4, 5, 8) . Growth curves of the strains listed in Table 1 were measured in mannose-containing liquid medium M-9 (without glucose) at 37 and 23 C. All strains were capS+ unless otherwise noted.
RESULTS

Mapping
b Final growth is the optical density at which portions were taken to measure polysaccharide after growth in liquid M-9 minimal medium at 23 C containing glucose or mannose as indicated.
c As micrograms of nondialyzable methylpentose per mililiter per unit of optical density at 600 mp. d Expressed as micromoles reduced nicotinamide adenine dinucleotide produced per hour per milligram of protein. All extracts were also assayed for G6P dehydrogenase and PGI at the time the PMI assays were performed. The range of specific activities enzymatic of G6P dehydrogenase was from 5.6 to 13.8; the average -i the standard deviation was 7.63 i 2.07. The range of specific enzymatic activities of PGI, except where noted otherwise (vide infra) was from 7.40 to 14.6, and the average of those not given specifically 4i the standard deviation was 10.0 2.3. Specific enzymatic activity of PGI of the following genotypes were: capR9 man+ (glucose-grown) = 21; capR6 man+ (glucose-grown) = 19; capR+ man-i (mannose-grown) = 22.
nose-positive revertants of strain MC119 (capR+ man-2) appeared similar to strain MC125 (capR9 man-2) ( Table 1) . If the mannose-positive mucoid revertants were a result of mutation of capR+ to capR, then we should be able to transduce the revertants back to nonmucoid mannose-negative phenotype with bacteriophage P1 grown on a capR+ proC+ strain by selecting for proC+ transductants (the recipients were proC). When three independent mannose-positive mucoid revertants were transduced toproC+ with P1 (capR+ proC+), 19% of proC+ transductants were nonmucoid. The proCF nonmucoid transductants did not replicate on mannose-containing medium, but the proC+ mucoid transductants did. The results indicate that the mucoid, mannose-positive revertants are the result of mutation of capR. In particular, the revertants exhibited a phenotype more like capR9 than like capR6 (Table 1) . DISCUSSION The present results demonstrate that phosphomannose isomerase is derepressed four-to fivefold in capR-type mucoid mutants. A limited derepression of phosphoglucose isomerase was also noted, but G6P dehydrogenase was not derepressed. Another type of mucoid mutation (capS) was mapped near trp. The capS-type mucoid mutant did not have elevated levels of PMI, nor did it contain increased levels of several other enzymes found to be elevated in capR-type mucoid mutants, including UDP-galactose-4-epimerase and GDP-mannose hydrolyase (5) .
Thus, two mechanisms may operate to produce mucoid clones, both of which produce large amounts of the same capsular polysaccharide (5, 6; Markovitz, unpublished data) . The capR mutants also differ from the capS mutants in that the former are sensitive to killing by ultraviolet light (6) whereas the latter are not (Markovitz, unpublished data). The capS type mucoid mutant may be a result of alteration in the structure of one of the enzymes of polysaccharide synthesis to a form that is no longer subject to feedback inhibition. Alterations in control of many pathways are of this type (2 In liquid medium containing mannose as sole carbon and energy source at 23 C, strains that contain either man-i or man-2 and a capR9 or capR6 allele grow quite well. Similarly, revertants to a mannose-positive mucoid phenotype occurred when strain MC119 (capR+ man-2) was plated on mannose agar at 37 C, and these revertants were shown to be caused by a mutation at the capR locus. Thus, capR gene mutations act as suppressors of the mannose-negative phenotype. The mechanism of suppression is not simply the derepression of PMI by capR mutations, since mannose itself derepresses PMI to the same extent in strains MC118 (capRY man-i) and MC119 (capR+ man-2) and these two strains grow extremely slowly on mannose even at 23 C. Further investigations are required to resolve this problem.
